Don Schneider, Piper Sandler deputy head of U.S. policy, and Marc Goldwein, CRFB SVP and senior policy director, join CNBC's ...

Piper Sandler analyst Alexander Potter upgraded Aptive PLC (NYSE:APTV) stock rating from Underweight to Neutral and increased ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Piper Sandler raised the firm’s price target on Tesla (TSLA) to $500 from $315 and keeps an Overweight rating on the shares. The firm says ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive option as credit spreads narrow.

Tesla shares TSLA ended the day down 0.6%, after falling as much as 4% intraday, tracking losses in the broader EV space, ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...